Background Elevation of systemic oxygen delivery and consumption has been associated
with an improved outcome in critically ill patients. We conducted a randomized trial to …

Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic
variation influences the development of illness requiring critical care 1 or hospitalization 2 , 3 – …

Importance Small trials suggest that postoperative outcomes may be improved by the use of
cardiac output monitoring to guide administration of intravenous fluid and inotropic drugs as …

Background Effective targeted therapy for sepsis requires an understanding of the
heterogeneity in the individual host response to infection. We investigated this heterogeneity by …

Objective: To investigate the effect of escalating doses of norepinephrine, aimed at achieving
incremental increases in mean arterial pressure (MAP), on microvascular flow and tissue …

Host-mediated lung inflammation is present 1 , and drives mortality 2 , in the critical illness
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …

Background The administration of growth hormone can attenuate the catabolic response to
injury, surgery, and sepsis. However, the effect of high doses of growth hormone on the …

Introduction Little is known about mortality rates following general surgical procedures in the
United Kingdom. Deaths are most common in the 'high-risk' surgical population consisting …

The jurors identified numerous problems with end of life in the ICU including variability in
practice, inadequate predictive models for death, elusive knowledge of patient preferences, …

Persistent neuromuscular and neurophysiologic abnormalities... : Critical Care Medicine
Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of …